Data accumulated from cancer research indicate a variety of theoretical parallels between signaling pathways that drive tumorigenesis [16,17], and those that regulate cardiac hypertrophy [5,10,11], a major common signal transduction pathway being represented by the Raf-ERK1/2 cascade. The gene discussed is MAPK3; the disease is cardiac hypertrophy.